The push to implement risk-based monitoring is continuing across the industry, yet many sponsors are struggling to find the right methods and technology to implement risk-based monitoring, resulting in a time-consuming and expensive effort.

How ICH E6(R2) has given clinical development organizations the perfect opportunity to improve quality and lower costs through adoption of RBM and Centralized Monitoring.